Warner Chilcott Can't Nix Pay-For-Delay Row: Loestrin Buyers
Warner Chilcott PLC should not be allowed to duck pay-for-delay multidistrict litigation concerning the contraceptive pill Loestrin, as amended claims concerning the allegations were properly filed, direct and indirect purchasers told...To view the full article, register now.
Already a subscriber? Click here to view full article